sem zeiss evo 60 s Search Results


91
Eldex Laboratories hp a-60-s
Hp A 60 S, supplied by Eldex Laboratories, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/HP+A-60-S/custom%401005%407169062
Average 91 stars, based on 1 article reviews
hp a-60-s - by Bioz Stars, 2026-10
91/100 stars
  Buy from Supplier

90
Hodag Chemical Corporation polyoxyl 12 stearate
Polyoxyl 12 Stearate, supplied by Hodag Chemical Corporation, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/polyoxyl+12+stearate/us11787820-261-99-98
Average 90 stars, based on 1 article reviews
polyoxyl 12 stearate - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ActiGraph llc gt1m
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Gt1m, supplied by ActiGraph llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/actigraph+gt3x/pmc09106641-22-31-30
Average 90 stars, based on 1 article reviews
gt1m - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
ActiGraph llc actigraph 60-s epoch
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Actigraph 60 S Epoch, supplied by ActiGraph llc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/actigraph+epoch/10__1249_slash_mss__0b013e3181cea100-85-18-65
Average 90 stars, based on 1 article reviews
actigraph 60-s epoch - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
RR Mechatronics spectrophotometer starrcol sc-60-s
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Spectrophotometer Starrcol Sc 60 S, supplied by RR Mechatronics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/starrcol+sc+60+s/pmc02000769-114-23-25
Average 90 stars, based on 1 article reviews
spectrophotometer starrcol sc-60-s - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

95
Cell Signaling Technology Inc tra 1 60 s
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Tra 1 60 S, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/TRA-1-60(S)+(TRA-1-60(S))+Mouse+mAb/pmc07346764-20-0-6
Average 95 stars, based on 1 article reviews
tra 1 60 s - by Bioz Stars, 2026-10
95/100 stars
  Buy from Supplier

90
BASF s-maz 60
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
S Maz 60, supplied by BASF, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/s+maz++65k/us09109126-249-0-2
Average 90 stars, based on 1 article reviews
s-maz 60 - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Furuuchi Chemical Corp round si rods
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Round Si Rods, supplied by Furuuchi Chemical Corp, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/si+round+rods/10__1149_slash_2__0121708jes-105-12-17
Average 90 stars, based on 1 article reviews
round si rods - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioSpec minibeadbeater
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Minibeadbeater, supplied by BioSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/minibeadbeater/pm19843251-209-5-9
Average 90 stars, based on 1 article reviews
minibeadbeater - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BioSpec minibeadbeatertm
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Minibeadbeatertm, supplied by BioSpec, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/mini+beadbeatertm/us08269062-99-5-9
Average 90 stars, based on 1 article reviews
minibeadbeatertm - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
Verlag GmbH diabetologia
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Diabetologia, supplied by Verlag GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/diabetologia/10__1007_slash_bf00586280-6-5-10
Average 90 stars, based on 1 article reviews
diabetologia - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
PAL Technologies Ltd activpal 3 tm
Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group
Activpal 3 Tm, supplied by PAL Technologies Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/sem+zeiss+evo+60+s/activpal3tm/pmc06231536-533-21-27
Average 90 stars, based on 1 article reviews
activpal 3 tm - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group

Journal: Osteoporosis International

Article Title: A comparison of the associations between bone health and three different intensities of accelerometer-derived habitual physical activity in children and adolescents: a systematic review

doi: 10.1007/s00198-021-06218-5

Figure Lengend Snippet: Study characteristics, accelerometry methods used and the relationships reported between MPA and/or MVPA and VPA with measures of bone health in children and adolescents for the 30 reviewed studies. Studies are grouped and presented by imaging method and study type (cross-sectional or longitudinal/prospective) then by epoch length (≥ 60 s, ≤ 15 s, raw data) and alphabetically within each epoch group

Article Snippet: Sayers et al. 2011 [ ] Cross-sectional ◆◆ , n = 1748 (778/970) 15.4 ± 0.23 years ALSPAC Tanner stages 1–2/3/4–5 (%): m, 2/12/86 f, 1/8/91 , MTI 7164 or Actigraph GT1M 60-s epoch Location: right hip Worn for: 7 days during waking hours (except WB activity) For inclusion: ≥ 3 days with ≥ 10 h Non-wear: NR , MPA, 3600–6199 cpm VPA, > 6200 cpm (min/day) MPA : m, 25.6 ± 17.1; f, 15.8 ± 13.2 VPA : m, 4.3 ± 5.8 f, 2.2 ± 3.7 , pQCT (Stratec XCT2000L) Mid (50%) right tibia BMCc (mg), BMDc (mg/cm 3 ), BAc (mm 2 ), PC (mm), EC (mm) , Linear regression was used to examine associations between MPA and VPA and pQCT bone outcomes (adjusted for age and height at time of pQCT measurement and duration of accelerometer recording) β coefficient represents SD change in pQCT parameter per doubling in MPA or VPA Cortical BMC: Boys: MPA : β ( 95% CI ) = 0.011 (− 0.033, 0.054), p = 0.6303; VPA : β ( 95% CI ) = 0.041 (0.004, 0.077), p = 0.0280 Girls: MPA : β ( 95% CI ) = 0.033 (− 0.002, 0.068), p = 0.0656; VPA : β ( 95% CI ) = 0.070 (0.031, 0.109), p = 0.0004 All: MPA : β ( 95% CI ) = 0.024 (− 0.003, 0.051), p = 0.0835; VPA : β ( 95% CI ) = 0.055 (0.028, 0.081), p = 0.00001 Cortical BA: Boys: MPA : β ( 95% CI ) = 0.022 (− 0.019, 0.062), p = 0.2959; VPA : β ( 95% CI ) = 0.050 (0.016, 0.085), p = 0.0039 Girls: MPA : β ( 95% CI ) = 0.032 (− 0.001, 0.065), p = 0.0611; VPA : β ( 95% CI ) = 0.068 (0.032, 0.105), p = 0.0002 All: MPA : β ( 95% CI ) = 0.028 (0.002, 0.053), p = 0.0347; VPA : β ( 95% CI ) = 0.059 (0.034, 0.084), p = 0.0000 Cortical BMD: Boys: MPA : β ( 95% CI ) = − 0.055 (− 0.095, − 0.015), p = 0.0074; VPA : β ( 95% CI ) = − 0.048 (− 0.082, − 0.014), p = 0.0062 Girls: MPA : β ( 95% CI ) = − 0.004 (− 0.037, 0.028), p = 0.7893; VPA : β ( 95% CI ) = − 0.012 (− 0.048, 0.024), p = 0.5206 All: MPA : β ( 95% CI ) = − 0.025 (− 0.050, 0.001), p = 0.0574; VPA : β ( 95% CI ) = − 0.031 (− 0.056, − 0.006), p = 0.0150 Periosteal circumference: Boys: MPA : β ( 95% CI ) = − 0.009 (− 0.050, 0.031), p = 0.6486; VPA : β ( 95% CI ) = 0.020 (− 0.015, 0.054), p = 0.2671 Girls: MPA : β ( 95% CI ) = 0.032 (− 0.001, 0.065), p = 0.0606; VPA : β ( 95% CI ) = 0.057 (0.021, 0.094), p = 0.0022 All: MPA : β ( 95% CI ) = 0.015 (− 0.010, 0.041), p = 0.2439; VPA: β ( 95% CI ) = 0.037 (0.012, 0.063), p = 0.0037 Endosteal circumference (adjusted periosteal circumference): Boys: MPA : β ( 95% CI ) = − 0.029 (− 0.064, 0.005), p = 0.0946; VPA : β ( 95% CI ) = − 0.044 (− 0.073, − 0.015), p = 0.0033 Girls: MPA : β ( 95% CI ) = − 0.012 (− 0.041, 0.016), p = 0.3901; VPA : β ( 95% CI ) = − 0.038 (− 0.069, − 0.007), p = 0.0167 All: MPA : β ( 95% CI ) = − 0.019 (− 0.041, 0.003), p = 0.0848; VPA : β ( 95% CI ) = − 0.041 (− 0.062, − 0.020), p = 0.00002.

Techniques: Imaging, Software, Activity Assay, Transformation Assay

A summary of the accelerometer data collection and processing methods used in all studies included in the review ( N = 30)

Journal: Osteoporosis International

Article Title: A comparison of the associations between bone health and three different intensities of accelerometer-derived habitual physical activity in children and adolescents: a systematic review

doi: 10.1007/s00198-021-06218-5

Figure Lengend Snippet: A summary of the accelerometer data collection and processing methods used in all studies included in the review ( N = 30)

Article Snippet: Sayers et al. 2011 [ ] Cross-sectional ◆◆ , n = 1748 (778/970) 15.4 ± 0.23 years ALSPAC Tanner stages 1–2/3/4–5 (%): m, 2/12/86 f, 1/8/91 , MTI 7164 or Actigraph GT1M 60-s epoch Location: right hip Worn for: 7 days during waking hours (except WB activity) For inclusion: ≥ 3 days with ≥ 10 h Non-wear: NR , MPA, 3600–6199 cpm VPA, > 6200 cpm (min/day) MPA : m, 25.6 ± 17.1; f, 15.8 ± 13.2 VPA : m, 4.3 ± 5.8 f, 2.2 ± 3.7 , pQCT (Stratec XCT2000L) Mid (50%) right tibia BMCc (mg), BMDc (mg/cm 3 ), BAc (mm 2 ), PC (mm), EC (mm) , Linear regression was used to examine associations between MPA and VPA and pQCT bone outcomes (adjusted for age and height at time of pQCT measurement and duration of accelerometer recording) β coefficient represents SD change in pQCT parameter per doubling in MPA or VPA Cortical BMC: Boys: MPA : β ( 95% CI ) = 0.011 (− 0.033, 0.054), p = 0.6303; VPA : β ( 95% CI ) = 0.041 (0.004, 0.077), p = 0.0280 Girls: MPA : β ( 95% CI ) = 0.033 (− 0.002, 0.068), p = 0.0656; VPA : β ( 95% CI ) = 0.070 (0.031, 0.109), p = 0.0004 All: MPA : β ( 95% CI ) = 0.024 (− 0.003, 0.051), p = 0.0835; VPA : β ( 95% CI ) = 0.055 (0.028, 0.081), p = 0.00001 Cortical BA: Boys: MPA : β ( 95% CI ) = 0.022 (− 0.019, 0.062), p = 0.2959; VPA : β ( 95% CI ) = 0.050 (0.016, 0.085), p = 0.0039 Girls: MPA : β ( 95% CI ) = 0.032 (− 0.001, 0.065), p = 0.0611; VPA : β ( 95% CI ) = 0.068 (0.032, 0.105), p = 0.0002 All: MPA : β ( 95% CI ) = 0.028 (0.002, 0.053), p = 0.0347; VPA : β ( 95% CI ) = 0.059 (0.034, 0.084), p = 0.0000 Cortical BMD: Boys: MPA : β ( 95% CI ) = − 0.055 (− 0.095, − 0.015), p = 0.0074; VPA : β ( 95% CI ) = − 0.048 (− 0.082, − 0.014), p = 0.0062 Girls: MPA : β ( 95% CI ) = − 0.004 (− 0.037, 0.028), p = 0.7893; VPA : β ( 95% CI ) = − 0.012 (− 0.048, 0.024), p = 0.5206 All: MPA : β ( 95% CI ) = − 0.025 (− 0.050, 0.001), p = 0.0574; VPA : β ( 95% CI ) = − 0.031 (− 0.056, − 0.006), p = 0.0150 Periosteal circumference: Boys: MPA : β ( 95% CI ) = − 0.009 (− 0.050, 0.031), p = 0.6486; VPA : β ( 95% CI ) = 0.020 (− 0.015, 0.054), p = 0.2671 Girls: MPA : β ( 95% CI ) = 0.032 (− 0.001, 0.065), p = 0.0606; VPA : β ( 95% CI ) = 0.057 (0.021, 0.094), p = 0.0022 All: MPA : β ( 95% CI ) = 0.015 (− 0.010, 0.041), p = 0.2439; VPA: β ( 95% CI ) = 0.037 (0.012, 0.063), p = 0.0037 Endosteal circumference (adjusted periosteal circumference): Boys: MPA : β ( 95% CI ) = − 0.029 (− 0.064, 0.005), p = 0.0946; VPA : β ( 95% CI ) = − 0.044 (− 0.073, − 0.015), p = 0.0033 Girls: MPA : β ( 95% CI ) = − 0.012 (− 0.041, 0.016), p = 0.3901; VPA : β ( 95% CI ) = − 0.038 (− 0.069, − 0.007), p = 0.0167 All: MPA : β ( 95% CI ) = − 0.019 (− 0.041, 0.003), p = 0.0848; VPA : β ( 95% CI ) = − 0.041 (− 0.062, − 0.020), p = 0.00002.

Techniques: Activity Assay, Derivative Assay